Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moshe Giladi

Showing results (61-70 of 100) with videos related to

Pageof 10
Sort By:
Clinical & Experimental Metastasis|April 24, 2009
Alternating electric fields (TTFields) inhibit metastatic spread of solid tumors to the lungsEilon D Kirson, Moshe Giladi, Zoya Gurvich, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|February 22, 2014
Mitotic disruption and reduced clonogenicity of pancreatic cancer cells in vitro and in vivo by tumor treating fieldsMoshe Giladi, Rosa S Schneiderman, Yaara Porat, et al.
The Journal of Investigative Dermatology|November 16, 2025
Pathogenic variants affecting peptidyl arginine deiminase 3 and its major substrates underlie central centrifugal cicatricial alopeciaNoy Keller-Rosenthal, Ofer Sarig, Moshe Giladi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 1, 2025
Testing the effects of topical skin care products on Tumor Treating Fields (TTFields) adhesiveness of arrays and delivery of electric currentsMaya Sadovnik, Sewar Zbidat, Mariell Sellevoll, et al.
International Journal of Molecular Sciences|December 30, 2025
Pro-Inflammatory Macrophage Phenotype Skewing Induced by Tumor Treating Fields (TTFields)Tal Kan, Yiftah Barsheshet, Tharwat Haj Khalil, et al.
The British Journal of Dermatology|July 13, 2022
Heterozygous variants in the integrin subunit beta 4 gene (ITGB4) cause autosomal dominant nail dystrophyKiril Malovitski, Odile Meijers, Eran Cohen-Barak, et al.
Oncogene|December 1, 2023
Revealing the tumor suppressive sequence within KL1 domain of the hormone KlothoMarana Abboud, Keren Merenbakh-Lamin, Hadas Volkov, et al.
International Journal of Molecular Sciences|March 11, 2023
Aurora B Kinase Inhibition by AZD1152 Concomitant with Tumor Treating Fields Is Effective in the Treatment of Cultures from Primary and Recurrent GlioblastomasDietmar Krex, Paula Bartmann, Doris Lachmann, et al.
Elife|July 2, 2021
Two <i>de novo</i> GluN2B mutations affect multiple NMDAR-functions and instigate severe pediatric encephalopathyShai Kellner, Abeer Abbasi, Ido Carmi, et al.
Frontiers in Oncology|July 12, 2021
<i>In Vivo</i> Safety of Tumor Treating Fields (TTFields) Applied to the TorsoRoni Blatt, Shiri Davidi, Mijal Munster, et al.
Pageof 10

Showing results (61-70 of 100) with videos related to

Sort By:
Pageof 10
Clinical & Experimental Metastasis|April 24, 2009
Alternating electric fields (TTFields) inhibit metastatic spread of solid tumors to the lungsEilon D Kirson, Moshe Giladi, Zoya Gurvich, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|February 22, 2014
Mitotic disruption and reduced clonogenicity of pancreatic cancer cells in vitro and in vivo by tumor treating fieldsMoshe Giladi, Rosa S Schneiderman, Yaara Porat, et al.
The Journal of Investigative Dermatology|November 16, 2025
Pathogenic variants affecting peptidyl arginine deiminase 3 and its major substrates underlie central centrifugal cicatricial alopeciaNoy Keller-Rosenthal, Ofer Sarig, Moshe Giladi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 1, 2025
Testing the effects of topical skin care products on Tumor Treating Fields (TTFields) adhesiveness of arrays and delivery of electric currentsMaya Sadovnik, Sewar Zbidat, Mariell Sellevoll, et al.
International Journal of Molecular Sciences|December 30, 2025
Pro-Inflammatory Macrophage Phenotype Skewing Induced by Tumor Treating Fields (TTFields)Tal Kan, Yiftah Barsheshet, Tharwat Haj Khalil, et al.
The British Journal of Dermatology|July 13, 2022
Heterozygous variants in the integrin subunit beta 4 gene (ITGB4) cause autosomal dominant nail dystrophyKiril Malovitski, Odile Meijers, Eran Cohen-Barak, et al.
Oncogene|December 1, 2023
Revealing the tumor suppressive sequence within KL1 domain of the hormone KlothoMarana Abboud, Keren Merenbakh-Lamin, Hadas Volkov, et al.
International Journal of Molecular Sciences|March 11, 2023
Aurora B Kinase Inhibition by AZD1152 Concomitant with Tumor Treating Fields Is Effective in the Treatment of Cultures from Primary and Recurrent GlioblastomasDietmar Krex, Paula Bartmann, Doris Lachmann, et al.
Elife|July 2, 2021
Two <i>de novo</i> GluN2B mutations affect multiple NMDAR-functions and instigate severe pediatric encephalopathyShai Kellner, Abeer Abbasi, Ido Carmi, et al.
Frontiers in Oncology|July 12, 2021
<i>In Vivo</i> Safety of Tumor Treating Fields (TTFields) Applied to the TorsoRoni Blatt, Shiri Davidi, Mijal Munster, et al.
Pageof 10